Securing the exemption from CVA charges in the new bank capital rules within the EU was a crucial element of the EACT's campaign to ensure that OTC derivatives continued to be available to corporates for risk management and that the pricing remained competitive. Policy in the United States towards the CVA exemption has been and remains a concern to the EACT. In March, the EACT Chairman wrote to Mr Daniel Pinto, Co-CEO Corporate & Investment at JP Morgan, to seek clarity on the position of the bank with respect to the EU CVA exemption and to ask what action has been undertaken by the bank in the last six months. In his response, Mr. Pinto stated that JP Morgan has not called for a repeal of the CVA exemption for corporate end users, yet also expressed concern that the approach by the regulators was not globally consistent and, as such, creates competitive inequalities.
The EACT is pleased to invite its members for nominations for the 4th EACT Award.View More
This year marks the 15th anniversary of the Association of Polish Corporate Treasurers. The 20th August, 2007 is the foundation day of the AssociationView More
EACT Award 2022: And the Winner is... For the 3rd year in a row, the EACT recognises a project realised within the European Treasury Community.View More
We wish you and your loved ones a happy holiday season and a new year filled with joy, prosperity and happiness.View More
The European Association of Corporate Treasurers (EACT) announces the appointment of François Masquelier as its new Chair as from October 1st.View More